Cresset Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.3M | Sell |
14,143
-184
| -1% | -$81.9K | 0.03% | 322 |
|
|
2025
Q1 | $6.95M | Sell |
14,327
-1,691
| -11% | -$820K | 0.03% | 291 |
|
|
2024
Q4 | $6.45M | Sell |
16,018
-8,025
| -33% | -$3.23M | 0.03% | 297 |
|
|
2024
Q3 | $11.2M | Buy |
24,043
+8,004
| +50% | +$3.72M | 0.04% | 275 |
|
|
2024
Q2 | $7.52M | Buy |
16,039
+4,005
| +33% | +$1.88M | 0.03% | 336 |
|
|
2024
Q1 | $5.03M | Buy |
12,034
+961
| +9% | +$402K | 0.02% | 376 |
|
|
2023
Q4 | $4.51M | Buy |
11,073
+1,808
| +20% | +$736K | 0.03% | 359 |
|
|
2023
Q3 | $3.22M | Sell |
9,265
-1,234
| -12% | -$429K | 0.01% | 395 |
|
|
2023
Q2 | $3.69M | Buy |
10,499
+9,110
| +656% | +$3.21M | ﹤0.01% | 366 |
|
|
2023
Q1 | $438K | Buy |
+1,389
| New | +$438K | 0.01% | 520 |
|
|
2022
Q4 | – | Sell |
-1,812
| Closed | -$524K | – | 905 |
|
|
2022
Q3 | $524K | Sell |
1,812
-345
| -16% | -$99.8K | 0.01% | 497 |
|
|
2022
Q2 | $605K | Sell |
2,157
-850
| -28% | -$238K | 0.01% | 500 |
|
|
2022
Q1 | $785K | Buy |
3,007
+453
| +18% | +$118K | 0.01% | 472 |
|
|
2021
Q4 | $560K | Sell |
2,554
-465
| -15% | -$102K | 0.01% | 662 |
|
|
2021
Q3 | $548K | Buy |
3,019
+502
| +20% | +$91.1K | 0.01% | 585 |
|
|
2021
Q2 | $508K | Buy |
2,517
+152
| +6% | +$30.7K | 0.01% | 549 |
|
|
2021
Q1 | $508K | Buy |
2,365
+585
| +33% | +$126K | 0.01% | 476 |
|
|
2020
Q4 | $421K | Sell |
1,780
-317
| -15% | -$75K | 0.01% | 444 |
|
|
2020
Q3 | $570K | Buy |
2,097
+165
| +9% | +$44.9K | 0.01% | 348 |
|
|
2020
Q2 | $561K | Buy |
1,932
+542
| +39% | +$157K | 0.01% | 318 |
|
|
2020
Q1 | $331K | Buy |
1,390
+253
| +22% | +$60.2K | 0.01% | 362 |
|
|
2019
Q4 | $249K | Buy |
+1,137
| New | +$249K | 0.01% | 491 |
|
|
2019
Q3 | – | Sell |
-1,212
| Closed | -$222K | – | 564 |
|
|
2019
Q2 | $222K | Buy |
1,212
+104
| +9% | +$19.1K | 0.01% | 417 |
|
|
2019
Q1 | $204K | Buy |
1,108
+602
| +119% | +$111K | 0.01% | 370 |
|
|
2018
Q4 | $84K | Buy |
+506
| New | +$84K | 0.01% | 368 |
|